10Y annualized return is
excellent
at 16.2% per year
RMD has met or exceeded earnings expectations in
the majority of
recent quarters (8/10)
Strong Return on Equity
Healthy Profit Margins
High Price-to-Earnings Ratio
Currency Headwinds
Get access to all key takeaways, detailed financial metrics, and comprehensive stock analysis with our premium subscription.
Already have an account? Sign in
ResMed demonstrates strong business quality through significant revenue growth, a robust competitive position, and substantial R&D investment. Future prospects are bolstered by emerging consumer partnerships and the potential of GLP-1 medications, despite potential delays in adoption. The company is well-positioned to leverage ongoing trends in medtech and digital health.
Analysis Date: January 30, 2025
Last Updated: May 29, 2025
Past performance does not guarantee future results. The data presented is indicative and may not be updated in real-time.
ResMed Inc. makes medical devices and software that help people with breathing problems, especially those who have sleep apnea. They create products like masks and machines that help people breathe better at home or in hospitals. Additionally, they offer helpful software that allows doctors to monitor patients' health remotely. Founded in 1989 and based in San Diego, California, ResMed sells its products to hospitals and health clinics in around 140 countries.
Streams of revenue
Geographic Distribution
Core Products
Business Type
Business to Business
Competitive Advantages
Discover all competitive advantages and strategic moats that protect RMD's market position.
View Premium AnalysisKey Business Risks
Get comprehensive insight into all key business risks that could impact RMD's performance.
Access Full Risk AnalysisTrailing Twelve Months (TTM) values provide a view of the company's performance over the last year.
Benjamin Graham's value investing approach focuses on finding stocks with a significant margin of safety between their intrinsic value and market price.
Access Benjamin Graham's value investing criteria, intrinsic value calculations, and margin of safety analysis
Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.
Profitability metrics measure a company's ability to generate earnings relative to its revenue, operating costs, and other relevant metrics. Higher values generally indicate better performance.
Access detailed profitability metrics with visual gauges and benchmarks
Access detailed analysis of profitability strengths and positive performance indicators
Upgrade to PremiumAccess detailed analysis of profitability weaknesses and areas of concern
Upgrade to PremiumFinancial health metrics assess a company's ability to meet its financial obligations and its overall financial stability.
Access detailed financial health metrics with visual gauges and risk assessments
Access detailed analysis of financial health strengths and stability indicators
Upgrade to PremiumAccess detailed analysis of financial health weaknesses and risk factors
Upgrade to PremiumMeeting Expectations
Higher values indicate better execution and credibility
Recent Results
View complete earnings history and detailed performance analysis
Upgrade to PremiumEPS
Revenue
Insider trading data shows purchase and sale activities by company executives and board members.
Insider trading patterns can provide insights into how company executives and board members view the stock's future prospects.
Get complete insider sentiment analysis with detailed trading patterns, sentiment indicators, and trend insights
